GlassScriptPhysician profile
Catriona M Swift
NPI 1164782157
$3,880.45
in general payments reported to CMS, 2019-2025
14 companies · $1,481 in 2025
The $1,481 reported for 2025 was more than what 77% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $238 · 2020: $15.11 · 2021: $1,498 · 2022: $88.82 · 2023: $548 · 2024: $11.52 · 2025: $1,481.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,212 · Travel and Lodging: $829.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,211.71 |
| Travel and Lodging | $828.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,337.23 | 2019-2025 | Da Vinci Surgical System |
| Boston Scientific Corporation | $1,242.79 | 2025 | Overstitch Endoscopic Suturing System |
| Organogenesis INC. | $45.48 | 2019 | |
| Janssen Biotech, INC. | $42.13 | 2025 | Tremfya |
| Endogastric Solutions, INC | $41.24 | 2023 | Esophyx |
| Medtronic, INC. | $37.70 | 2023 | Signia |
| Integra Lifesciences Corporation | $24.71 | 2019 | |
| Ambu INC. | $20.06 | 2021 | |
| Melinta Therapeutics, LLC | $19.88 | 2021 | |
| Baudax Bio INC. | $15.11 | 2020 | |
| Polarityte, INC. | $14.43 | 2019 | |
| Apollo Endosurgery US INC | $13.55 | 2021 | |
| Merck Sharp & Dohme LLC | $13.24 | 2019 | |
| Currax Pharmaceuticals LLC | $12.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catriona Swift listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.